Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
S Tag Peptide: Technical Guidance for Fusion Tag Application
2026-05-28
S Tag Peptide (SKU A6007) addresses common bottlenecks in recombinant protein detection, purification, and solubility by providing a small, highly soluble fusion tag compatible with anti-S-Tag antibody detection. It should be used when high solubility and robust affinity purification are required, but is not suitable for applications needing direct enzymatic activity from the tag itself or ethanol-based workflows.
-
FXR-KLF11 Axis Suppresses JAK2/STAT3 to Mitigate CI-AKI
2026-05-28
This study reveals that activation of the FXR-KLF11 transcriptional axis confers protection against contrast-induced acute kidney injury (CI-AKI) by suppressing JAK2/STAT3-mediated inflammation and apoptosis. The findings highlight a mechanistic advance in CI-AKI pathogenesis and propose FXR agonists as promising prophylactic therapeutics.
-
Renin–Angiotensin System Peptides and SARS-CoV-2 Entry via A
2026-05-27
A recent study reveals that while Angiotensin II does not modulate SARS-CoV-2 entry via ACE2, its downstream metabolite angiotensin IV can both enhance and inhibit viral entry in a concentration-dependent manner. These findings clarify the distinct roles of renin–angiotensin system peptides in viral infectivity and suggest new considerations for research at the intersection of cardiovascular and infectious disease.
-
Hydrocortisone in Translational Research: Mechanisms to Impa
2026-05-27
Explore how hydrocortisone’s mechanistic depth as a glucocorticoid hormone empowers translational researchers to bridge inflammation, stress response, and neuroprotection studies. This article uniquely connects cutting-edge findings in cancer stemness and therapy resistance, with actionable protocol guidance and a clear perspective on product selection and workflow integration.
-
Omeprazole (A2845): Technical Guidance for Research Use
2026-05-26
Omeprazole (SKU A2845) provides a standardized H+,K+-ATPase inhibitor resource for research on gastric acid secretion and antiulcer mechanisms. It is optimized for in vitro and preclinical workflows but is not suitable for diagnostic, clinical, or cross-domain applications. Researchers should follow strict handling and solubility protocols to ensure reproducibility and avoid stability-related errors.
-
Annexin V-APC/7-AAD Apoptosis Kit: Precision Apoptosis Detec
2026-05-26
The Annexin V-APC/7-AAD Apoptosis Kit enables rapid, dual-parameter apoptosis and necrosis detection with high sensitivity. This apoptosis detection kit leverages phosphatidylserine binding and membrane integrity assessment for robust cell death analysis. The kit is validated for use in cancer, immunology, and cell biology research under rigorous conditions.
-
Forskolin: Precision cAMP Modulation for Translational Succe
2026-05-25
Explore how Forskolin, a direct adenylate cyclase activator, transforms translational research workflows. This thought-leadership article bridges molecular insight, validated protocols, and cross-domain relevance, offering strategic guidance for stem cell, cardiovascular, and viral infection models.
-
Minoxidil Sulphate in Vascular and Hair Growth Research Work
2026-05-25
Minoxidil sulphate, the active metabolite of minoxidil, is a high-purity research standard for probing vasodilation and hair follicle mechanisms. This article details experimental protocols, troubleshooting tactics, and recent insights from vascular biology, highlighting how APExBIO’s validated compound enhances reproducibility in preclinical workflows.
-
Rapamycin-Induced Autophagy Mitigates Lipotoxicity in Salmon
2026-05-24
A recent study demonstrates that stimulating autophagy with rapamycin promotes lipid breakdown and reduces lipotoxicity in Atlantic salmon SHK-1 cells. These findings establish a mechanistic link between autophagy activation and lipid homeostasis in fish, offering a new cell-based model for studying metabolic regulation relevant to aquaculture.
-
PTBP2 Attenuation Enhances Direct Fibroblast-to-Neuron Conve
2026-05-23
The reference study demonstrates that reducing PTBP2 expression markedly improves the efficiency of converting human skin fibroblasts into induced neurons by promoting neuron-specific alternative splicing, particularly in synergy with RBFOX3. These findings provide mechanistic insight into cellular reprogramming strategies for neurodegenerative disease research and highlight alternative splicing modulation as a key axis for direct lineage conversion.
-
Adefovir Dipivoxil: Advances in Chronic Hepatitis B Therapy
2026-05-22
Hadziyannis and Papatheodoridis's review delineates the clinical and mechanistic advances enabled by adefovir dipivoxil (GS-0393) in treating chronic hepatitis B, highlighting its efficacy in both wild-type and lamivudine-resistant HBV. Their analysis provides foundational evidence for the compound's long-term safety profile and its significance as a nucleotide analog antiviral.
-
Pazopanib Hydrochloride: Optimizing Anti-Angiogenic Assays
2026-05-22
Pazopanib Hydrochloride (GW786034) empowers cancer research with robust multi-target kinase inhibition, enabling precise dissection of angiogenesis and tumor growth pathways. This guide details advanced experimental workflows, troubleshooting strategies, and actionable insights to unleash the full potential of Pazopanib in preclinical oncology models.
-
ISRIB (trans-isomer): Novel Insights for Cognitive Memory an
2026-05-21
Discover how ISRIB (trans-isomer), a potent PERK inhibitor, offers unique advantages for dissecting neuroinflammation and memory loss. This article unpacks new experimental evidence and practical assay guidance for cognitive and neurodegenerative disease research.
-
MitMAB in Translational Endocytosis: Mechanistic Precision f
2026-05-21
This thought-leadership article explores how MitMAB, a potent dynamin GTPase inhibitor, is transforming endocytosis and membrane trafficking research in advanced organoid models. Drawing from recent breakthroughs in milk-derived extracellular vesicle uptake, we map the intersection of mechanistic insight and strategic protocol guidance, highlighting MitMAB’s unique value for translational researchers seeking reproducibility and physiologic relevance.
-
Lactate-GPR81/FARP1 Axis Drives Insulin-Independent Glucose
2026-05-20
This study identifies the lactate-activated GPR81/FARP1 signaling pathway as a critical regulator of insulin-independent glucose uptake in skeletal muscle. By elucidating the mechanism underlying exercise-induced glycemic control, it opens new avenues for metabolic disease intervention beyond insulin-centric therapies.